Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 117

Similar articles for PubMed (Select 23933054)

1.

Changes in plasma Brain-derived neurotrophic factor (BDNF) levels induced by methylphenidate in children with Attention deficit-hyperactivity disorder (ADHD).

Amiri A, Torabi Parizi G, Kousha M, Saadat F, Modabbernia MJ, Najafi K, Atrkar Roushan Z.

Prog Neuropsychopharmacol Biol Psychiatry. 2013 Dec 2;47:20-4. doi: 10.1016/j.pnpbp.2013.07.018. Epub 2013 Aug 8.

PMID:
23933054
2.

Effect of methylphenidate treatment on appetite and levels of leptin, ghrelin, adiponectin, and brain-derived neurotrophic factor in children and adolescents with attention deficit and hyperactivity disorder.

Sahin S, Yuce M, Alacam H, Karabekiroglu K, Say GN, Salıs O.

Int J Psychiatry Clin Pract. 2014 Oct;18(4):280-7. doi: 10.3109/13651501.2014.940054. Epub 2014 Sep 16.

PMID:
24994482
3.

Increased levels of plasma brain-derived neurotrophic factor (BDNF) in children with attention deficit-hyperactivity disorder (ADHD).

Shim SH, Hwangbo Y, Kwon YJ, Jeong HY, Lee BH, Lee HJ, Kim YK.

Prog Neuropsychopharmacol Biol Psychiatry. 2008 Dec 12;32(8):1824-8. doi: 10.1016/j.pnpbp.2008.08.005. Epub 2008 Aug 8.

PMID:
18760321
4.

Val/Val genotype of brain-derived neurotrophic factor (BDNF) Val⁶⁶Met polymorphism is associated with a better response to OROS-MPH in Korean ADHD children.

Kim BN, Cummins TD, Kim JW, Bellgrove MA, Hong SB, Song SH, Shin MS, Cho SC, Kim JH, Son JW, Shin YM, Chung US, Han DH.

Int J Neuropsychopharmacol. 2011 Nov;14(10):1399-410. doi: 10.1017/S146114571100099X. Epub 2011 Jun 28.

PMID:
21733227
5.

Changes in the serum levels of brain-derived neurotrophic factor in adults with attention deficit hyperactivity disorder after treatment with atomoxetine.

Ramos-Quiroga JA, Corominas-Roso M, Palomar G, Gomez-Barros N, Ribases M, Sanchez-Mora C, Bosch R, Nogueira M, Corrales M, Valero S, Casas M.

Psychopharmacology (Berl). 2014 Apr;231(7):1389-95. doi: 10.1007/s00213-013-3343-y. Epub 2013 Nov 8.

PMID:
24202115
6.
7.

Attention-deficit/hyperactivity disorder and comorbid subsyndromal depression: what is the impact of methylphenidate on mood?

Golubchik P, Kodesh A, Weizman A.

Clin Neuropharmacol. 2013 Sep-Oct;36(5):141-5. doi: 10.1097/WNF.0b013e31829eb204.

PMID:
24045603
8.

Treadmill exercise and methylphenidate ameliorate symptoms of attention deficit/hyperactivity disorder through enhancing dopamine synthesis and brain-derived neurotrophic factor expression in spontaneous hypertensive rats.

Kim H, Heo HI, Kim DH, Ko IG, Lee SS, Kim SE, Kim BK, Kim TW, Ji ES, Kim JD, Shin MS, Choi YW, Kim CJ.

Neurosci Lett. 2011 Oct 17;504(1):35-9. doi: 10.1016/j.neulet.2011.08.052. Epub 2011 Aug 31.

PMID:
21907264
9.

Methylphenidate treatment and dyskinesia in children with attention-deficit/hyperactivity disorder.

Balázs J, Dallos G, Keresztény A, Czobor P, Gádoros J.

J Child Adolesc Psychopharmacol. 2011 Apr;21(2):133-8. doi: 10.1089/cap.2010.0030. Epub 2011 Apr 12.

PMID:
21486166
10.

Efficacy of methylphenidate in patients with cerebral palsy and attention-deficit hyperactivity disorder (ADHD).

Gross-Tsur V, Shalev RS, Badihi N, Manor O.

J Child Neurol. 2002 Dec;17(12):863-6.

PMID:
12593456
11.

Transition from methylphenidate or amphetamine to atomoxetine in children and adolescents with attention-deficit/hyperactivity disorder--a preliminary tolerability and efficacy study.

Quintana H, Cherlin EA, Duesenberg DA, Bangs ME, Ramsey JL, Feldman PD, Allen AJ, Kelsey DK.

Clin Ther. 2007 Jun;29(6):1168-77.

PMID:
17692731
12.

Ginkgo biloba for attention-deficit/hyperactivity disorder in children and adolescents: a double blind, randomized controlled trial.

Salehi B, Imani R, Mohammadi MR, Fallah J, Mohammadi M, Ghanizadeh A, Tasviechi AA, Vossoughi A, Rezazadeh SA, Akhondzadeh S.

Prog Neuropsychopharmacol Biol Psychiatry. 2010 Feb 1;34(1):76-80. doi: 10.1016/j.pnpbp.2009.09.026. Epub 2009 Oct 5.

PMID:
19815048
13.

A dose-response study of OROS methylphenidate in children with attention-deficit/hyperactivity disorder.

Stein MA, Sarampote CS, Waldman ID, Robb AS, Conlon C, Pearl PL, Black DO, Seymour KE, Newcorn JH.

Pediatrics. 2003 Nov;112(5):e404.

PMID:
14595084
14.

Norepinephrine transporter gene (SLC6A2) is involved with methylphenidate response in Korean children with attention deficit hyperactivity disorder.

Song J, Song DH, Jhung K, Cheon KA.

Int Clin Psychopharmacol. 2011 Mar;26(2):107-13. doi: 10.1097/YIC.0b013e32834152d1.

PMID:
21127421
15.

Common and unique therapeutic mechanisms of stimulant and nonstimulant treatments for attention-deficit/hyperactivity disorder.

Schulz KP, Fan J, Bédard AC, Clerkin SM, Ivanov I, Tang CY, Halperin JM, Newcorn JH.

Arch Gen Psychiatry. 2012 Sep;69(9):952-61. doi: 10.1001/archgenpsychiatry.2011.2053.

PMID:
22945622
16.
17.

Methylphenidate effects on blood serotonin and melatonin levels may help to synchronise biological rhythms in children with ADHD.

Molina-Carballo A, Naranjo-Gómez A, Uberos J, Justicia-Martínez F, Ruiz-Ramos MJ, Cubero-Millán I, Contreras-Chova F, Augustin-Morales MD, Khaldy-Belkadi H, Muñoz-Hoyos A.

J Psychiatr Res. 2013 Mar;47(3):377-83. doi: 10.1016/j.jpsychires.2012.09.020. Epub 2012 Oct 22.

PMID:
23088865
18.

Ningdong granule: a complementary and alternative therapy in the treatment of attention deficit/hyperactivity disorder.

Li JJ, Li ZW, Wang SZ, Qi FH, Zhao L, Lv H, Li AY.

Psychopharmacology (Berl). 2011 Aug;216(4):501-9. doi: 10.1007/s00213-011-2238-z. Epub 2011 Mar 18.

PMID:
21416235
19.

Serum brain-derived neurotrophic factor (BDNF) levels in attention deficit-hyperactivity disorder (ADHD).

Scassellati C, Zanardini R, Tiberti A, Pezzani M, Valenti V, Effedri P, Filippini E, Conte S, Ottolini A, Gennarelli M, Bocchio-Chiavetto L.

Eur Child Adolesc Psychiatry. 2014 Mar;23(3):173-7. doi: 10.1007/s00787-013-0447-1. Epub 2013 Jun 28.

PMID:
23812866
20.

Low dopamine transporter occupancy by methylphenidate as a possible reason for reduced treatment effectiveness in ADHD patients with cocaine dependence.

Crunelle CL, van den Brink W, Veltman DJ, van Emmerik-van Oortmerssen K, Dom G, Schoevers RA, Booij J.

Eur Neuropsychopharmacol. 2013 Dec;23(12):1714-23. doi: 10.1016/j.euroneuro.2013.05.002. Epub 2013 May 31.

PMID:
23731497
Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk